Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β₂-agonists in the United Kingdom: a cross-sectional analysis

Affiliations

¹ Respiratory Medicine Unit, Nuffield Department of Medicine, NDM Research Building, Old Road Campus, University of Oxford, Oxford, OX3 7FZ, UK. ian.pavord@ndm.ox.ac.uk.
² Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, UK.
³ Kantar Health, Health Outcomes Practice, 19-31 Church Street, Epsom, Surrey, KT17 4PF, UK.
⁴ RTI Health Solutions, Avinguda Diagonal, 605, 9-1, Barcelona, 08028, Spain.
⁵ Academic Primary Care, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.

Published Erratum

Ian D Pavord et al. NPJ Prim Care Respir Med. 2017.

. 2017 Dec 5;27(1):65.

doi: 10.1038/s41533-017-0063-5.

¹ Respiratory Medicine Unit, Nuffield Department of Medicine, NDM Research Building, Old Road Campus, University of Oxford, Oxford, OX3 7FZ, UK. ian.pavord@ndm.ox.ac.uk.
² Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, UK.
³ Kantar Health, Health Outcomes Practice, 19-31 Church Street, Epsom, Surrey, KT17 4PF, UK.
⁴ RTI Health Solutions, Avinguda Diagonal, 605, 9-1, Barcelona, 08028, Spain.
⁵ Academic Primary Care, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.

Abstract

A correction to this article has been published and is linked from the HTML version of this article.

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β₂-agonists in the United Kingdom: a cross-sectional analysis.
Pavord ID, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D. Pavord ID, et al. NPJ Prim Care Respir Med. 2017 Mar 9;27(1):17. doi: 10.1038/s41533-017-0014-1. NPJ Prim Care Respir Med. 2017. PMID: 28270657 Free PMC article.